Definium Therapeutics, Inc. Common Shares (NASDAQ: DFTX) last traded at $36.90, up 7.96% on the session. The quote above updates while this page is open; the figures below are drawn from Definium Therapeutics, Inc. Common Shares’s own filings and are restated only when a new one is published.
Definium Therapeutics, Inc. Common Shares trades on NASDAQ under the ticker DFTX. Its market capitalisation is $4.96 billion.
Valuation measures for Definium Therapeutics, Inc. Common Shares, derived from the latest quote and its most recent SEC filing.
| Market cap | $4.96B |
|---|---|
| Enterprise value | $4.50B |
| Price / book | 5.40 |
| Beta | 0.98 |
Trailing-twelve-month figures tagged in Definium Therapeutics, Inc. Common Shares's XBRL filings with the SEC.
| Net income (TTM) |
|---|
| -$353.79M |
| EPS (TTM) | -$3.36 |
|---|
| Return on equity | -38.51% |
|---|
| Cash | $655.27M |
|---|
Range and volume for DFTX over the past 52 weeks.
| 52-week high | $49.70 |
|---|---|
| 52-week low | $10.47 |
| Volume | 2.77M |
| Average volume | 2.14M |
| Previous close | $34.18 |
Invest a chosen dollar amount in Definium Therapeutics, Inc. Common Shares with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell DFTX.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.